Phospholipase D2 regulates endothelial permeability through cytoskeleton reorganization and occludin downregulation.. Phospholipase D2 regulates endothelial permeability through cytoskeleton reorganization and occludin downregulation.: PLD2 and endothelial permeability

Archive ouverte

Zeiller, Caroline | Mebarek, Saïda | Jaafar, Rami | Pirola, Luciano | Lagarde, Michel | Prigent, Annie-France | Némoz, Georges

Edité par CCSD ; Elsevier -

International audience. Endothelial permeability is controlled by adhesive strengths which connect cells to each other through interendothelial junctions and by contractile forces associated with cytoskeleton reorganization. Phospholipase D (PLD) activation resulting in the generation of phosphatidic acid (PA) is increasingly recognized as a key event in the initiation of various cell responses. In human umbilical vein endothelial cells (HUV-EC), enhancement of intracellular PA by a variety of approaches increased the permeability of endothelial cell monolayers and induced stress fibre formation. Using adenovirus-mediated overexpression and siRNA silencing, we showed that PLD2 but not PLD1 was involved in the enhancement of basal permeability through cytoskeleton reorganization. Furthermore, PLD2 overexpression induced ERK1/2 activation and downregulated the expression of occludin, a major component of tight junctions. A substantial part of PLD2 protein was associated with the low-density caveolin-rich fractions isolated on sucrose gradients. The Raf-1 specific inhibitor GW-5074 drastically reduced hyperpermeability induced by PLD2 overexpression, and inhibited PA-mediated increase of endothelial permeability and ERK1/2 activation. On the whole, the present results demonstrate the selective role of PLD2 isoform in the control of endothelial permeability through a mechanism involving both stress fibre formation and contraction, and occludin downregulation, possibly resulting from PA-mediated activation of Raf-1.

Suggestions

Du même auteur

Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation.

Archive ouverte | Mebarek, Saïda | CCSD

International audience. In L6 skeletal myoblasts induced to differentiate by Arg8-vasopressin treatment, a short-lived lowering of ceramide levels was observed, followed by a long-lasting elevation that was prevente...

Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis.. : DHA supplementation and immune function

Archive ouverte | Mebarek, Saïda | CCSD

International audience. Dietary intake of long-chain n-3 PUFA has been reported to decrease several markers of lymphocyte activation and modulate monocyte susceptibility to apoptosis. However, most human studies exa...

Phospholipase D regulates myogenic differentiation through the activation of both mTORC1 and mTORC2 complexes.. Phospholipase D regulates myogenic differentiation through the activation of both mTORC1 and mTORC2 complexes.: Phospholipase D and mTOR in myogenesis

Archive ouverte | Jaafar, Rami | CCSD

International audience. How phospholipase D (PLD) is involved in myogenesis remains unclear. At the onset of myogenic differentiation of L6 cells induced by the PLD agonist vasopressin in the absence of serum, mTORC...

Chargement des enrichissements...